Received Jul 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Suspected vaccination failure; My cousin got the vaccine and got shingles in his eye; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) solution for injection for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and ophthalmic herpes zoster (Verbatim: My cousin got the vaccine and got shingles in his eye) (serious criteria GSK medically significant). The outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster was resolving. It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingrix. The company considered the vaccination failure and ophthalmic herpes zoster to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 12-JUL-2026 This case was reported by a patient via interactive digital media. The reporter stated that the shingles vaccine gave the shingles. The reporter's cousin got the vaccine and got shingles in his eye, took over a year to somewhat heal. The reporter said that stop taking every vaccine which was offered. This case was considered as suspected vaccination failure since the details regarding primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The batch number was not provided and we and unable to contact the reporter.; Sender's Comments: A case of Vaccination failure, and Ophthalmic herpes zoster, On an unknown date, after vaccination with Shingrix in a male patient. Based on the available information a possible causality that the events were caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.